Alpha1,3-galactosyltransferase gene-knockout pigs for xenotransplantation: where do we go from here?
about
Coagulation dysregulation as a barrier to xenotransplantation in the primateHepatic function after genetically engineered pig liver transplantation in baboons.Mechanisms of xenogeneic baboon platelet aggregation and phagocytosis by porcine liver sinusoidal endothelial cells.Overcoming the barriers to xenotransplantation: prospects for the futureCurrent status of xenotransplantation and prospects for clinical applicationThe innate immune response and activation of coagulation in alpha1,3-galactosyltransferase gene-knockout xenograft recipientsHuman immune reactivity against liver sinusoidal endothelial cells from GalTα(1,3)GalT-deficient pigs.Initial in vivo experience of pig artery patch transplantation in baboons using mutant MHC (CIITA-DN) pigsInitial in vitro investigation of the human immune response to corneal cells from genetically engineered pigsRegenerative medicine as applied to general surgeryThe porcine lung as a potential model for cystic fibrosisXenotransplantation literature update May-August, 2007.Frankenswine, or bringing home the bacon: How close are we to clinical trials in xenotransplantation?Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts.Progress and prospects: genetic engineering in xenotransplantation.Xenotransplantation: the next generation of engineered animalsAchieving tolerance in pig-to-primate xenotransplantation: reality or fantasy.Update: cardiac xenotransplantation.Complement activation and coagulation in xenotransplantation.Pig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit?Antibody-mediated xenograft injury: mechanisms and protective strategies.Xenotransplantation--the future of corneal transplantation?Advancing pig cloning technologies towards application in regenerative medicine.The role of platelets in coagulation dysfunction in xenotransplantation, and therapeutic options.Lung xenotransplantation: recent progress and current status.The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of xenocorneal transplantation.Spatiotemporal control of porcine p65RHD expression by advanced Tet-On system in PIEC cells helps regulate NFкB activity.Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells.Suppression of NF-kappaB p65 expression attenuates delayed xenograft rejection.Advances in organ transplant from pigs.Altered expression of eNOS, prostacyclin synthase, prostaglandin G/H synthase, and thromboxane synthase in porcine aortic endothelial cells after exposure to human serum-relevance to xenotransplantation.Efficient generation of genetically distinct pigs in a single pregnancy using multiplexed single-guide RNA and carbohydrate selection.Relative efficiency of porcine and human cytotoxic T-lymphocyte antigen 4 immunoglobulin in inhibiting human CD4+ T-cell responses co-stimulated by porcine and human B7 moleculesComplement dependent early immunological responses during ex vivo xenoperfusion of hCD46/HLA-E double transgenic pig forelimbs with human blood
P2860
Q33381973-456140DF-1A8C-4202-BE2E-EF4730C390F4Q33390545-DCD7EA97-B932-4D06-84D3-508D64A911BCQ33404184-B2B16BE6-1486-4D76-A9ED-D179BA6467DAQ33801035-44AB92AD-83F8-4F1F-9373-C0844E2520CEQ33835678-1C46C288-6937-4699-B371-2094B503A980Q34055520-5484225B-8E2F-4468-AA7D-757C742B73D0Q34213417-38F58ECC-386C-418B-B5CD-08F05E3721D4Q35202459-17733641-E0CD-447B-9415-54A524DCE4B4Q35221353-C136EF98-5332-4381-A4F7-93A682C3A234Q35892487-7CEB57FD-17BA-47AD-9F3E-B9E24967F45FQ36846439-E70BD415-285D-4105-B2B2-0CA1AB0092FDQ36996589-1B9FBEB2-717A-427E-8198-6C764050FCEDQ37080101-47B47519-9E87-4482-A0A4-79C98A4600D2Q37196570-03B9ED0F-4446-4B6C-A0FD-C49C2B41A9A0Q37258233-1B488A12-0708-4E4C-8519-8536D8F9B32FQ37313536-5B464A7E-52E1-4913-8EDE-E803A54EB848Q37342291-F0536A34-F628-409A-958D-69D52FB393CEQ37342534-4A2F26EC-B26E-4DAB-A71D-E02870A6E089Q37372498-012AEDF3-2E9D-477F-9CCD-7D3FA6D4BE45Q37424698-B8F54D66-6E97-42A3-8893-1D1E13EAE0E1Q37450148-701398F6-73BD-4D93-8B99-7C75E2C9CE2DQ37811749-23AE261D-6C74-4B76-8F0C-0D8623F59DA4Q38029031-8A717742-B17A-4233-8A26-26A355231E4FQ38191251-535BFFC2-9635-4FA2-8EC5-020E02249327Q38231495-5B74B6BA-0F6D-4434-B22A-898E83086FF5Q38245175-99A10C2F-72F5-4A78-B525-65D87D49CCB1Q39032896-DA405F5D-59DA-4627-87F6-4BA9992689DBQ43185385-5C217468-9597-4E36-A654-918CBCF3B9B2Q46264106-78F638A1-578C-4DC7-AA6E-5CED94F541F1Q49953449-F7434BBB-1F48-4D49-8A60-2BA12620089BQ50893567-38E1DAF4-9F9E-4436-8948-961519A2A1B5Q51058644-D1446EEB-83B8-4613-BDF9-BFD5559D88B7Q56898413-8D128FE1-6FE1-49B3-BD7A-F96B138BAB25Q57197924-D0E2CBF6-44FD-4EAA-B57B-6B13D98C2355
P2860
Alpha1,3-galactosyltransferase gene-knockout pigs for xenotransplantation: where do we go from here?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Alpha1,3-galactosyltransferase ...... ion: where do we go from here?
@en
type
label
Alpha1,3-galactosyltransferase ...... ion: where do we go from here?
@en
prefLabel
Alpha1,3-galactosyltransferase ...... ion: where do we go from here?
@en
P2093
P1433
P1476
Alpha1,3-galactosyltransferase ...... ion: where do we go from here?
@en
P2093
David Ayares
David K C Cooper
Hideki Ohdan
Jorg Seebach
Mark Yazer
Michael Rees
Michel Awwad
Richard N Pierson
P356
10.1097/01.TP.0000260427.75804.F2
P577
2007-07-01T00:00:00Z